Home› Europe› EEA Joint Committee› Decision of the EEA Joint Committee No 180/2023 of 5 July 20...
Date: 21-Mar-2024 Category: Not Applicable State: Union Government Country: Europe

Decision of the EEA Joint Committee No 180/2023 of 5 July 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/799]

Issued by EEA Joint Committee · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • The EEA Joint Committee Decision No 180/2023 amends Annex II to the EEA Agreement to incorporate Commission Implementing Decision (EU) 2022/2298. This decision pertains to postponing the expiry date of the approval of propiconazole for use in biocidal products of product-type 8, in accordance with Regulation (EU) No 528/2012.

Key Changes

  • Annex II to the EEA Agreement is amended to include point 12zzzzzzzzy, referencing Commission Implementing Decision (EU) 2022/2298.
  • Commission Implementing Decision (EU) 2022/2298 postpones the expiry date of the approval of propiconazole for use in biocidal products of product-type 8.
  • The decision entered into force on 6 July 2023, following notifications under Article 103(1) of the EEA Agreement.
  • The text of Implementing Decision (EU) 2022/2298 in Icelandic and Norwegian languages will be published in the EEA Supplement to the Official Journal of the European Union and shall be authentic.

Impact Analysis

Stakeholders Impacted

  • The agricultural sector and other industries that rely on biocidal products of product-type 8 may be affected by the continued availability of propiconazole.

Suggested Action Items

  • Government agencies should communicate the changes to relevant industries and ensure compliance with the updated regulations.

Key Entities Referenced

EEA Joint Committee: The body responsible for adopting decisions related to the EEA Agreement. Commission Implementing Decision (EU) 2022/2298: The specific decision postponing the expiry date of the approval of propiconazole for use in biocidal products of product-type 8. EEA Agreement: The Agreement on the European Economic Area. Regulation (EU) No 528/2012: Regulation of the European Parliament and of the Council concerning the making available on the market and use of biocidal products.
Official Source Record View Original Source →
See Full Document Text
Official Journal EN of the European Union L series 2024/799 21.3.2024 DECISION OF THE EEA JOINT COMMITTEE No 180/2023 of 5 July 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/799] THE EEA JOINT COMMITTEE, Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof, Whereas: (1) Commission Implementing Decision (EU) 2022/2298 of 23 November 2022 postponing the expiry date of the approval of propiconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council(1)is to be incorporated into the EEA Agreement. (2) Annex II to the EEA Agreement should therefore be amended accordingly, HAS ADOPTED THIS DECISION: Article 1 The following point is inserted after point 12zzzzzzzzx (Commission Implementing Decision (EU) 2022/2570) of Chapter XV of Annex II to the EEA Agreement: ‘12zzzzzzzzy. 32022 D 2298: Commission Implementing Decision (EU) 2022/2298 of 23 November 2022postponing the expiry date of the approval of propiconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 304, 24.11.2022, p. 85).’ Article 2 The text of Implementing Decision (EU) 2022/2298 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic. Article 3 This Decision shall enter into force on 6 July 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made*. Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union. Done at Brussels, 5 July 2023. For the EEA Joint Committee The President Pascal SCHAFHAUSER (1) OJ L 304, 24.11.2022, p. 85. * No constitutional requirements indicated. ELI: http://data.europa.eu/eli/dec/2024/799/oj 1/1

Continue your research

Related Documents from EEA Joint Committee